Advertisement

Latest News

BW-20805 Reduces HAE Attacks in Phase 2 Trial, With Markus Magerl, MD

1 hour ago

At AAAAI 2026, Magerl discusses phase 2 data showing BW-20805 reduced hereditary angioedema attacks by up to 100% with dosing intervals of up to 6 months.

AMI Mortality Increasing Among Young Adults With Nontraditional Risk Factors, With Mohan Satish, MD

2 hours ago

Satish discusses his recent study highlighting significant increases in first AMI in-hospital mortality among young adults, particularly in women.

New Long-Term Data Announced on Roflumilast Cream for Atopic Dermatitis in Children

2 hours ago

These data, resulting from the INTEGUMENT-OLE trial, highlight the efficacy and safety of roflumilast cream (ZORYVE) 0.05% in children aged 2 - 5 years.

FDA Approves Leucovorin Calcium (Wellcovorin) Tablets as First Cerebral Folate Deficiency Treatment

3 hours ago

The approval comes after the FDA requested GSK submit an sNDA for leucovorin for the treatment of CFD-FOLR1.

Skin of Color Savvy: Challenges and Successes in a Dermatologist’s Career, With Nicole Negbenebor, MD

3 hours ago

This March episode highlights one SOCS member’s journey in dermatology, covering clinical and research passions as well as lessons learned along the way.

Advertisement
Advertisement